1. Home
  2. KBH vs KNSA Comparison

KBH vs KNSA Comparison

Compare KBH & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$63.79

Market Cap

3.8B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$44.74

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBH
KNSA
Founded
1957
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.4B
IPO Year
1987
2018

Fundamental Metrics

Financial Performance
Metric
KBH
KNSA
Price
$63.79
$44.74
Analyst Decision
Hold
Strong Buy
Analyst Count
13
6
Target Price
$63.91
$52.33
AVG Volume (30 Days)
1.2M
598.3K
Earning Date
03-23-2026
02-24-2026
Dividend Yield
1.57%
N/A
EPS Growth
N/A
N/A
EPS
6.15
0.47
Revenue
$6,236,214,000.00
$597,973,000.00
Revenue This Year
N/A
$62.99
Revenue Next Year
$6.74
$33.30
P/E Ratio
$10.32
$95.77
Revenue Growth
N/A
55.68
52 Week Low
$48.90
$18.12
52 Week High
$68.71
$45.50

Technical Indicators

Market Signals
Indicator
KBH
KNSA
Relative Strength Index (RSI) 63.53 58.64
Support Level $59.89 $42.00
Resistance Level $62.84 $45.01
Average True Range (ATR) 2.04 1.58
MACD 0.56 0.12
Stochastic Oscillator 98.38 80.25

Price Performance

Historical Comparison
KBH
KNSA

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: